$6.91
2.40%
Nasdaq, Nov 18, 04:00 pm EST.
ISIN
CA74319B5027
Symbol
PROF

Profound Medical Corp Stock price

$6.91
+1.05 17.92% 1M
+0.02 0.29% 6M
-0.96 12.20% YTD
+0.68 10.91% 1Y
-4.27 38.19% 3Y
-5.03 42.13% 5Y
-0.49 6.66% 10Y
-3.28 32.16% 20Y
Nasdaq, Closing price Wed, Nov 18 2026
-0.17 2.40%

Is Profound Medical Corp a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,085 stocks worldwide.

Key metrics

Basic
Market capitalization
$257.0m
Enterprise Value
$228.1m
Net debt
positive
Cash
$33.3m
Shares outstanding
36.6m
Valuation
P/E
negative
P/S | estimate
10.9 | 9.5
EV/Sales | estimate
9.7 | 8.4
EV/FCF | ex SBC
negative | -
P/B
6.0
Financial Health
Equity Ratio
85.8%
Return on Equity
-64.1%
ROCE
-74.4%
ROIC
-150.3%
Debt/Equity
0.1
Financials
Revenue | estimate
$23.6m | $27.1m
EBITDA
$-33.8m
EBIT
$-34.3m
Net Income
$-32.5m
Free Cash Flow | ex SBC
$-31.5m | -
Growth
Revenue | estimate
65.2% | 68.1%
EBITDA
18.6%
EBIT
18.8%
Net Income
17.4%
Free Cash Flow
16.1%
Margin
Gross
73.9%
EBITDA
-143.1%
EBIT
-145.1%
Net
-137.5%
Free Cash Flow | ex SBC
-133.3% | -
More
EPS
$-0.9
FCF per Share
$-0.9
Short interest
4.9%
Employees
162
Rev per Employee
$100.0k

Profound Medical Corp Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a Profound Medical Corp forecast:

4x Buy
80%
1x Hold
20%

Analyst Opinions

5 Analysts have issued a Profound Medical Corp forecast:

Buy
80%
Hold
20%

Profound Medical Corp Events

Past Events
NOV
5
Q3 2026 Earnings Call
14 days ago
AUG
6
Q2 2026 Earnings Call
3 months ago
MAY
13
Shareholder/Analyst Call - Profound Medical Corp.
6 months ago
MAY
7
Q1 2026 Earnings Call
7 months ago
MAR
13
Special Call - Profound Medical Corp.
8 months ago
MAR
5
Q4 2025 Earnings Call
9 months ago
NOV
13
Q3 2025 Earnings Call
about one year ago

Financial data from Profound Medical Corp

Sep '26
+/-
%
24 24
65% 65%
100%
- Direct Costs 6.18 6.18
57% 57%
26%
17 17
68% 68%
74%
- Selling and Administrative Expenses 31 31
3% 3%
130%
- Research and Development Expense 21 21
0% 0%
89%
-34 -34
19% 19%
-143%
- Depreciation and Amortization 0.48 0.48
30% 30%
2%
EBIT (Operating Income) EBIT -34 -34
19% 19%
-145%
Net Profit -32 -32
17% 17%
-137%

In millions USD.

Don't miss a Thing! We will send you all news about Profound Medical Corp directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Profound Medical Corp Stock News

Neutral
GlobeNewsWire
●
10 days ago
TORONTO, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (iMRI) procedures, today announced that its President, Richard Fabian, will present at the Stifel 2026 Healthcare Conference on Thursday, November 12, 2026 at 8:40 a.m. Eastern Ti...
Neutral
GlobeNewsWire
●
20 days ago
New distribution agreement positions TULSA-PRO within the iMRI Suite offering through Cook Medical's Copernicus™ program, expanding Profound's commercial reach
More Profound Medical Corp News

Company Profile

Profound Medical Corp. develops, manufactures and markets therapeutic platforms that combine real-time magnetic resonance imaging with directional and focused ultrasound technology for incision-free ablation of diseased tissue. Its platforms offer clinicians and patients incision-free alternatives to current standards of care which could include traditional surgery or radiation therapy. Its products include TULSA-PRO and Sonalleve. The company was founded in 2008 and is headquartered in Mississauga, CA.

Head office Canada
CEO Dr. Menawat
Employees 162
Founded 2008
Website profoundmedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today